Cargando…

A study on HIV-infected individuals who reported CD4+ cell count below 100 cells/μl multiple times after more than 6 months of antiretroviral therapy at the apex tertiary referral hospital of India

Detalles Bibliográficos
Autores principales: Maurya, Shesh Prakash, Singh, Ravinder, Sinha, Sanjeev, Gautam, Hitender, Das, Bimal Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891014/
https://www.ncbi.nlm.nih.gov/pubmed/36743105
http://dx.doi.org/10.4103/ijstd.ijstd_103_21
_version_ 1784881056231456768
author Maurya, Shesh Prakash
Singh, Ravinder
Sinha, Sanjeev
Gautam, Hitender
Das, Bimal Kumar
author_facet Maurya, Shesh Prakash
Singh, Ravinder
Sinha, Sanjeev
Gautam, Hitender
Das, Bimal Kumar
author_sort Maurya, Shesh Prakash
collection PubMed
description
format Online
Article
Text
id pubmed-9891014
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-98910142023-02-02 A study on HIV-infected individuals who reported CD4+ cell count below 100 cells/μl multiple times after more than 6 months of antiretroviral therapy at the apex tertiary referral hospital of India Maurya, Shesh Prakash Singh, Ravinder Sinha, Sanjeev Gautam, Hitender Das, Bimal Kumar Indian J Sex Transm Dis AIDS Letters to Editor Wolters Kluwer - Medknow 2022 2022-08-01 /pmc/articles/PMC9891014/ /pubmed/36743105 http://dx.doi.org/10.4103/ijstd.ijstd_103_21 Text en Copyright: © 2022 Indian Journal of Sexually Transmitted Diseases and AIDS https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Letters to Editor
Maurya, Shesh Prakash
Singh, Ravinder
Sinha, Sanjeev
Gautam, Hitender
Das, Bimal Kumar
A study on HIV-infected individuals who reported CD4+ cell count below 100 cells/μl multiple times after more than 6 months of antiretroviral therapy at the apex tertiary referral hospital of India
title A study on HIV-infected individuals who reported CD4+ cell count below 100 cells/μl multiple times after more than 6 months of antiretroviral therapy at the apex tertiary referral hospital of India
title_full A study on HIV-infected individuals who reported CD4+ cell count below 100 cells/μl multiple times after more than 6 months of antiretroviral therapy at the apex tertiary referral hospital of India
title_fullStr A study on HIV-infected individuals who reported CD4+ cell count below 100 cells/μl multiple times after more than 6 months of antiretroviral therapy at the apex tertiary referral hospital of India
title_full_unstemmed A study on HIV-infected individuals who reported CD4+ cell count below 100 cells/μl multiple times after more than 6 months of antiretroviral therapy at the apex tertiary referral hospital of India
title_short A study on HIV-infected individuals who reported CD4+ cell count below 100 cells/μl multiple times after more than 6 months of antiretroviral therapy at the apex tertiary referral hospital of India
title_sort study on hiv-infected individuals who reported cd4+ cell count below 100 cells/μl multiple times after more than 6 months of antiretroviral therapy at the apex tertiary referral hospital of india
topic Letters to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891014/
https://www.ncbi.nlm.nih.gov/pubmed/36743105
http://dx.doi.org/10.4103/ijstd.ijstd_103_21
work_keys_str_mv AT mauryasheshprakash astudyonhivinfectedindividualswhoreportedcd4cellcountbelow100cellsmlmultipletimesaftermorethan6monthsofantiretroviraltherapyattheapextertiaryreferralhospitalofindia
AT singhravinder astudyonhivinfectedindividualswhoreportedcd4cellcountbelow100cellsmlmultipletimesaftermorethan6monthsofantiretroviraltherapyattheapextertiaryreferralhospitalofindia
AT sinhasanjeev astudyonhivinfectedindividualswhoreportedcd4cellcountbelow100cellsmlmultipletimesaftermorethan6monthsofantiretroviraltherapyattheapextertiaryreferralhospitalofindia
AT gautamhitender astudyonhivinfectedindividualswhoreportedcd4cellcountbelow100cellsmlmultipletimesaftermorethan6monthsofantiretroviraltherapyattheapextertiaryreferralhospitalofindia
AT dasbimalkumar astudyonhivinfectedindividualswhoreportedcd4cellcountbelow100cellsmlmultipletimesaftermorethan6monthsofantiretroviraltherapyattheapextertiaryreferralhospitalofindia
AT mauryasheshprakash studyonhivinfectedindividualswhoreportedcd4cellcountbelow100cellsmlmultipletimesaftermorethan6monthsofantiretroviraltherapyattheapextertiaryreferralhospitalofindia
AT singhravinder studyonhivinfectedindividualswhoreportedcd4cellcountbelow100cellsmlmultipletimesaftermorethan6monthsofantiretroviraltherapyattheapextertiaryreferralhospitalofindia
AT sinhasanjeev studyonhivinfectedindividualswhoreportedcd4cellcountbelow100cellsmlmultipletimesaftermorethan6monthsofantiretroviraltherapyattheapextertiaryreferralhospitalofindia
AT gautamhitender studyonhivinfectedindividualswhoreportedcd4cellcountbelow100cellsmlmultipletimesaftermorethan6monthsofantiretroviraltherapyattheapextertiaryreferralhospitalofindia
AT dasbimalkumar studyonhivinfectedindividualswhoreportedcd4cellcountbelow100cellsmlmultipletimesaftermorethan6monthsofantiretroviraltherapyattheapextertiaryreferralhospitalofindia